Aug. 19 at 7:10 AM
$ARDX $BROS $CRM $LAES Ardelyx advances kidney-related treatments, Dutch Bros benefits from store expansion and consumer demand, Salesforce benefits from enterprise software and AI adoption, and LAES remains focused on specialized technology development. I'm watching prescriptions, same-store sales, recurring revenue, AI monetization, and funding.